UB Paderborn / Katalog / Suche / in CDI

1 – 12 von 12

Sortiert nach

Androgen receptor (AR) heterogeneity in prostate cancer and therapy resistance

Cancer letters, 2021-10, Vol.518, p.1-9

2021

Volltextzugriff (PDF)

Characterization of Novel Murine and Human PDAC Cell Models: Identifying the Role of Intestine Specific Homeobox Gene ISX in Hypoxia and Disease Progression

Translational oncology, 2019-08, Vol.12 (8), p.1056-1071

2019

Volltextzugriff (PDF)

Abstract TMIM-064: AMPKA-LIKE PROTEINS IN OVARIAN CANCER TUMORIGENESIS AND NECROPTOSIS

Clinical cancer research, 2019-11, Vol.25 (22_Supplement), p.TMIM-064-TMIM-064

2019

Volltextzugriff (PDF)

Abstract GMM-019: MEK INHIBITOR TRAMETINIB IN HIGH GRADE OVARIAN CANCER PROLIFERATION

Clinical cancer research, 2019-11, Vol.25 (22_Supplement), p.GMM-019-GMM-019

2019

Volltextzugriff (PDF)

Phase Ib trial of enzalutamide (Enza) with venetoclax (Ven) in metastatic castration-resistant prostate cancer (mCRPC)

Journal of clinical oncology, 2023-02, Vol.41 (6_suppl), p.182-182

2023

Volltextzugriff (PDF)

Tissue factor pathway inhibitor-2 (TFPI-2)-an underappreciated partaker in cancer and metastasis

Cancer and metastasis reviews, 2024-08

2024

Volltextzugriff (PDF)

Integrated single-cell analysis defines the epigenetic basis of castration-resistant prostate luminal cells

Cell stem cell, 2024-08, Vol.31 (8), p.1203-1221.e7

2024

Volltextzugriff (PDF)

COMMD3:BMI1 Fusion and COMMD3 Protein Regulate C-MYC Transcription: Novel Therapeutic Target for Metastatic Prostate Cancer

Molecular cancer therapeutics, 2019-11, Vol.18 (11), p.2111-2123

2019

Volltextzugriff (PDF)

Abstract 2601: Lrig1 is a haplo-insufficient tumor suppressor and Lrig1-expressing cells can function as cells-of-origin of tumor development

Cancer research (Chicago, Ill.), 2023-04, Vol.83 (7_Supplement), p.2601-2601

2023

Volltextzugriff (PDF)

The Reverse Gyrase from Pyrobaculum calidifontis, a Novel Extremely Thermophilic DNA Topoisomerase Endowed with DNA Unwinding and Annealing Activities

The Journal of biological chemistry, 2014-02, Vol.289 (6), p.3231-3243

2014

Volltextzugriff (PDF)

Clinically and orally compatible formulation-manufactured DDX5 (p68)-targeting molecular glue FL118 products exhibit low toxicity but high efficacy against human cancer

Journal of pharmaceutical analysis, 2024-05, p.101001, Article 101001

2024

Volltextzugriff (PDF)

Characterization of Novel Murine and Human PDAC Cell Models: Identifying the Role of Intestine Specific Homeobox Gene ISX in Hypoxia and Disease Progression1

Translational oncology, 2019-06, Vol.12 (8), p.1056-1071

2019

Volltextzugriff (PDF)

1 – 12 von 12

Suche als RSS-Feed

Aktive Filter

ThemaGenetic Aspects

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(12)
Mit Volltextzugriff
(12)

Publikationsform

Artikel
(12)

Sprache

Englisch
(12)

Erscheinungsjahr

n.n

Neu hinzugefügt

... seit 30 Tagen
(1)
... seit 90 Tagen
(2)

Menü

Weitere Dienste

Einstellungen

Androgen receptor (AR) heterogeneity in prostate cancer and therapy resistance

Characterization of Novel Murine and Human PDAC Cell Models: Identifying the Role of Intestine Specific Homeobox Gene ISX in Hypoxia and Disease Progression

Abstract TMIM-064: AMPKA-LIKE PROTEINS IN OVARIAN CANCER TUMORIGENESIS AND NECROPTOSIS

Abstract GMM-019: MEK INHIBITOR TRAMETINIB IN HIGH GRADE OVARIAN CANCER PROLIFERATION

Phase Ib trial of enzalutamide (Enza) with venetoclax (Ven) in metastatic castration-resistant prostate cancer (mCRPC)

Tissue factor pathway inhibitor-2 (TFPI-2)-an underappreciated partaker in cancer and metastasis

Integrated single-cell analysis defines the epigenetic basis of castration-resistant prostate luminal cells

COMMD3:BMI1 Fusion and COMMD3 Protein Regulate C-MYC Transcription: Novel Therapeutic Target for Metastatic Prostate Cancer

Abstract 2601: Lrig1 is a haplo-insufficient tumor suppressor and Lrig1-expressing cells can function as cells-of-origin of tumor development

The Reverse Gyrase from Pyrobaculum calidifontis, a Novel Extremely Thermophilic DNA Topoisomerase Endowed with DNA Unwinding and Annealing Activities

Clinically and orally compatible formulation-manufactured DDX5 (p68)-targeting molecular glue FL118 products exhibit low toxicity but high efficacy against human cancer

Characterization of Novel Murine and Human PDAC Cell Models: Identifying the Role of Intestine Specific Homeobox Gene ISX in Hypoxia and Disease Progression1

Aktive Filter

Suchergebnisse filtern